Lexaria Bioscience (LEXX) Q1 2025 Earnings — Beat Estimates

Screener

Reported April 14, 2025 · Before market open

Revenue$174.0KBeat by $82.7K

EPS-$0.15Beat by $0.01

Revenue estimate$91.3K

EPS estimate-$0.16

Next report

Oct 28, 2026 (in 2 months)

Revenue estimate$50.0K

EPS estimate-$0.90

Versus estimates

Revenue

Q1 2026$20.0KMiss by $30.0K Q3 2025$174.0KBeat by $37.0K Q2 2025$174.0KBeat by $37.0K

Q1 2025$174.0KBeat by $82.7K

Diluted EPS

Q2 2026-$0.08Miss by $0.02 Q1 2026-$0.06Beat by $0.04 Q4 2025-$0.07Beat by $0.06 Q3 2025-$0.13Beat by $0.03 Q2 2025-$0.21Miss by $0.06

Q1 2025-$0.15Beat by $0.01

FAQ

When did Lexaria Bioscience report Q1 2025 earnings?: Lexaria Bioscience (LEXX) reported Q1 2025 earnings on April 14, 2025 before market open.
What were Lexaria Bioscience's Q1 2025 revenue and EPS?: Lexaria Bioscience reported revenue of $174.0K and eps of $-0.15 for Q1 2025.
Did Lexaria Bioscience beat estimates in Q1 2025?: Revenue beat the consensus estimate of $91.3K by $82.7K. EPS beat the consensus estimate of $-0.16 by $0.01.
Where can I find Lexaria Bioscience's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001640334-25-000629) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Lexaria Bioscience reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk